Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
Multiple Myeloma, Refractory
Athens, Attica
Multiple Myeloma, Refractory Clinical Trials in Athens, Attica
1 recruiting
Athens, Attica, Greece
Showing
1–1
of
1
trials
Recruiting
Phase 2
A Study of Selinexor (Seli) + Low-dose Dexamethasone (LDD) in Penta-refractory Multiple Myeloma (MM), Seli and Bortezomib + LDD in Triple-class Refractory MM.
Multiple Myeloma, Refractory
Karyopharm Therapeutics Inc
127 enrolled
16 locations
NCT04414475
Feedback